| March 2, 2026 | news | Smith+Nephew Fourth Quarter and Full Year 2025 Results This report details Smith+Nephew's strong financial performance in 2025, exceeding targets for revenue growth, profitability, and cash generation. It highlights the completion of the 12-Point Plan and the successful launch of the new RISE strategy, setting the stage for accelerated growth and new product introductions in 2026. The company also provided a positive outlook for 2026, targeting further progress in key financial metrics. |
| January 12, 2026 | news | Smith+Nephew strengthens shoulder repair portfolio with acquisition Smith+Nephew announced the acquisition of Integrity Orthopaedics, a US-based developer of the Tendon Seam™ rotator cuff repair system. This strategic acquisition is a key step in delivering Smith+Nephew's RISE strategy, aiming to accelerate growth through strategic investment and portfolio leadership, particularly in the Sports Medicine segment. The transaction is expected to be accretive to Group trading profit margin by 2028, reinforcing the company's commitment to innovation and market leadership. |
| December 8, 2025 | news | Smith+Nephew Announces New Strategy and 2028 Financial Targets Smith+Nephew unveiled its new "RISE" strategy, building on its previous 12-Point Plan, to drive enhanced financial and operational performance. The strategy focuses on reaching more patients, accelerating innovation, scaling through strategic investment, and efficient execution. The company also announced ambitious financial targets for 2028, including significant acceleration in revenue growth, profit, free cash flow, and Return on Invested Capital (ROIC). |